SPY311.54-4.64 -1.47%
DIA255.99-4.73 -1.81%
IXIC10,406.37-86.13 -0.82%

Cellectis Q3 EPS $(0.23) Beats $(0.8) Estimate, Sales $10.206M Beat $3.28M Estimate

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.8) by 71.25 percent. This is a 36.11 percent increase over losses of $(0.36) per share from the same

Benzinga · -

Cellectis (NASDAQ:CLLS) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.8) by 71.25 percent. This is a 36.11 percent increase over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $10.206 million which beat the analyst consensus estimate of $3.28 million by 211.16 percent. This is a 365.60 percent increase over sales of $2.192 million the same period last year.